Product liability claims and vaccines

<?xml version="1.0" encoding="UTF-8"?><collection xmlns="http://www.loc.gov/MARC21/slim" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.loc.gov/MARC21/slim http://www.loc.gov/standards/marcxml/schema/MARC21slim.xsd">
  <record>
    <leader>00000cab a2200000   4500</leader>
    <controlfield tag="001">MAP20200032199</controlfield>
    <controlfield tag="003">MAP</controlfield>
    <controlfield tag="005">20201013170251.0</controlfield>
    <controlfield tag="008">201009e20201001sgp|||p      |0|||b|eng d</controlfield>
    <datafield tag="040" ind1=" " ind2=" ">
      <subfield code="a">MAP</subfield>
      <subfield code="b">spa</subfield>
      <subfield code="d">MAP</subfield>
    </datafield>
    <datafield tag="084" ind1=" " ind2=" ">
      <subfield code="a">335</subfield>
    </datafield>
    <datafield tag="100" ind1="1" ind2=" ">
      <subfield code="0">MAPA20170000556</subfield>
      <subfield code="a">Khanna, Anoop</subfield>
    </datafield>
    <datafield tag="245" ind1="1" ind2="0">
      <subfield code="a">Product liability claims and vaccines</subfield>
      <subfield code="c">Anoop Khanna </subfield>
    </datafield>
    <datafield tag="520" ind1=" " ind2=" ">
      <subfield code="a">The COVID-19 pandemic rages on, spurring global efforts to develop vaccines to curb it. However, who is liable for claims for damages in case of any side-effects of the vaccines that are being developed on a fast track, is the million-dollar question.</subfield>
    </datafield>
    <datafield tag="650" ind1=" " ind2="4">
      <subfield code="0">MAPA20080630454</subfield>
      <subfield code="a">Responsabilidad civil de productos</subfield>
    </datafield>
    <datafield tag="650" ind1=" " ind2="4">
      <subfield code="0">MAPA20080567118</subfield>
      <subfield code="a">Reclamaciones</subfield>
    </datafield>
    <datafield tag="650" ind1=" " ind2="4">
      <subfield code="0">MAPA20200005599</subfield>
      <subfield code="a">COVID-19</subfield>
    </datafield>
    <datafield tag="650" ind1=" " ind2="4">
      <subfield code="0">MAPA20080552022</subfield>
      <subfield code="a">Pandemias</subfield>
    </datafield>
    <datafield tag="650" ind1=" " ind2="4">
      <subfield code="0">MAPA20080575342</subfield>
      <subfield code="a">Daños y perjuicios</subfield>
    </datafield>
    <datafield tag="650" ind1=" " ind2="4">
      <subfield code="0">MAPA20080634865</subfield>
      <subfield code="a">Seguro de responsabilidad civil de productos</subfield>
    </datafield>
    <datafield tag="650" ind1=" " ind2="4">
      <subfield code="0">MAPA20080586294</subfield>
      <subfield code="a">Mercado de seguros</subfield>
    </datafield>
    <datafield tag="773" ind1="0" ind2=" ">
      <subfield code="w">MAP20090003767</subfield>
      <subfield code="t">Asia insurance review</subfield>
      <subfield code="d">Singapore : Ins Communications Pte Ltd., 2009-</subfield>
      <subfield code="x">0218-2696</subfield>
      <subfield code="g">01/10/2020 Número 10 - octubre 2020 , p. 14-15</subfield>
    </datafield>
  </record>
</collection>